Exact Mass: 365.1297

Exact Mass Matches: 365.1297

Found 105 metabolites which its exact mass value is equals to given mass value 365.1297, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Acetylbialaphos

N-Acetylbialaphos; N-Acetylphosphinothricin tripeptide

C13H24N3O7P (365.1352)


   

2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

N-[(2R,3S,4R)-3-Hydroxy-2-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-pyran-5-yl]ethanimidate

C14H23NO10 (365.1322)


2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl- D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087) [HMDB] 2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl- D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087).

   

2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

N-[(2R,3S,4R)-4-Hydroxy-2-(hydroxymethyl)-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-pyran-5-yl]ethanimidate

C14H23NO10 (365.1322)


2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087) [HMDB] 2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087).

   

cucoline

(1R,9S,10S)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,11-tetraen-13-one;hydrochloride

C19H24ClNO4 (365.1394)


Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].

   

cucoline

(1R,9S,10S)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,11-tetraen-13-one;hydrochloride

C19H23NO4.HCl (365.1394)


Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].

   
   

N,O-Diacetylmichelalbin

N,O-Diacetylmichelalbin

C21H19NO5 (365.1263)


   
   
   

L-gamma-Glutamyl-S-3-(1-hydroxypropyl)-L-cysteinyl-glycine

L-gamma-Glutamyl-S-3-(1-hydroxypropyl)-L-cysteinyl-glycine

C13H23N3O7S (365.1257)


This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.

   

8-Hydroxydihydrochelerythrine

8-Hydroxydihydrochelerythrine

C21H19NO5 (365.1263)


   

Thaliglucinone

Thaliglucinone

C21H19NO5 (365.1263)


   
   

Didehydroocoteine

Didehydroocoteine

C21H19NO5 (365.1263)


   
   
   

6-Methoxy-7-hydroxydihydrochelerythrine

6-Methoxy-7-hydroxydihydrochelerythrine

C21H19NO5 (365.1263)


   

CHEMBL2334352

CHEMBL2334352

C21H19NO5 (365.1263)


   

lavendustin b

lavendustin b

C21H19NO5 (365.1263)


Lavendustin B is an inhibitor of HIV-1 integrase interaction with LEDGF/p75 with an IC50 of 94.07 μM. Lavendustin B is an ATP-competitive GLUT1 inhibitor with a Ki of 15 μM. Lavendustin B is also a weak inhibitor of tyrosine kinases[1][2].

   
   
   
   
   
   
   
   
   

THALICSINE

NCGC00160212-01!THALICSINE

C21H19NO5 (365.1263)


   

11-methoxyduguesuramine

11-methoxyduguesuramine

C21H19NO5 (365.1263)


   

N2-(Pyrene-1-yl)methyl-guanine

N2-(Pyrene-1-yl)methyl-guanine

C22H15N5O1 (365.1277)


   
   
   
   
   
   
   
   
   
   
   
   
   

2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

2-(acetylamino)-1,5-anhydro-2-deoxy-3-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

C14H23NO10 (365.1322)


   

2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol

C14H23NO10 (365.1322)


   

N-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]-2-(2-chloro-3,4-dimethoxyphenyl)ethylamine

N-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]-2-(2-chloro-3,4-dimethoxyphenyl)ethylamine

C19H24ClNO4 (365.1394)


   

1H-Indole,1-methyl-3-[5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-(9CI)

1H-Indole,1-methyl-3-[5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-(9CI)

C20H19N3O4 (365.1375)


   

Cloperastine hydrochloride

Cloperastine hydrochloride

C20H25Cl2NO (365.1313)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

1-butyl-2,3,3-trimethylbenzo[e]indol-3-ium,perchlorate

1-butyl-2,3,3-trimethylbenzo[e]indol-3-ium,perchlorate

C19H24ClNO4 (365.1394)


   

4-N-MALEIMIDOMETHYLCYCLOHEXANE-1-CARBOXYLHYDRAZIDE

4-N-MALEIMIDOMETHYLCYCLOHEXANE-1-CARBOXYLHYDRAZIDE

C14H18F3N3O5 (365.1198)


   

H-GABA-OBzl.TosOH

H-GABA-OBzl.TosOH

C18H23NO5S (365.1297)


   

1-[2-[(S)-(4-Chlorophenyl)phenylmethoxy]ethyl]piperidine hydrochloride

1-[2-[(S)-(4-Chlorophenyl)phenylmethoxy]ethyl]piperidine hydrochloride

C20H24ClNO.HCl (365.1313)


   

(S)-(-)-1-Fmoc-4-oxopiperidine-2-carboxylic acid

(S)-(-)-1-Fmoc-4-oxopiperidine-2-carboxylic acid

C21H19NO5 (365.1263)


   

(R)-(+)-1-Fmoc-4-oxopiperidine-2-carboxylic acid

(R)-(+)-1-Fmoc-4-oxopiperidine-2-carboxylic acid

C21H19NO5 (365.1263)


   

4-[(3-Ethynylphenyl)amino]-6,7-bis(2-hydroxyethoxy)quinazoline

4-[(3-Ethynylphenyl)amino]-6,7-bis(2-hydroxyethoxy)quinazoline

C20H19N3O4 (365.1375)


   

1-Piperazinecarboxamide, N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)-

1-Piperazinecarboxamide, N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)-

C19H19N5OS (365.131)


JNJ-1661010 (Takeda-25) a potent and selective fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 34 and 33 nM for rat FAAH and human FAAH, respectively. JNJ-1661010 can cross the blood-brain barrier and used as broad-spectrum analgesics[1][2].

   

methyl 9-O-acetyl-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid

methyl 9-O-acetyl-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid

C14H23NO10 (365.1322)


   

N-[2-hydroxy-2-(indol-3-yl)-2-(methylthio)ethyl]indole-3-carboxamide

N-[2-hydroxy-2-(indol-3-yl)-2-(methylthio)ethyl]indole-3-carboxamide

C20H19N3O2S (365.1198)


   
   

5-(5-Chloro-2,4-dihydroxyphenyl)-N-ethyl-4-piperazin-1-YL-1H-pyrazole-3-carboxamide

5-(5-Chloro-2,4-dihydroxyphenyl)-N-ethyl-4-piperazin-1-YL-1H-pyrazole-3-carboxamide

C16H20ClN5O3 (365.1255)


   

3-({[(3s)-3,4-Dihydroxybutyl]oxy}amino)-1h,2h-2,3-Biindol-2-One

3-({[(3s)-3,4-Dihydroxybutyl]oxy}amino)-1h,2h-2,3-Biindol-2-One

C20H19N3O4 (365.1375)


   

(2z,3e)-2,3-Biindole-2,3(1h,1h)-Dione 3-{o-[(3r)-3,4-Dihydroxybutyl]oxime}

(2z,3e)-2,3-Biindole-2,3(1h,1h)-Dione 3-{o-[(3r)-3,4-Dihydroxybutyl]oxime}

C20H19N3O4 (365.1375)


   

S-(3-Hydroxypropyl)glutathione

S-(3-Hydroxypropyl)glutathione

C13H23N3O7S (365.1257)


   

N-[(E)-(3,4-dimethoxyphenyl)methylideneamino]-2-quinolin-8-yloxyacetamide

N-[(E)-(3,4-dimethoxyphenyl)methylideneamino]-2-quinolin-8-yloxyacetamide

C20H19N3O4 (365.1375)


   

4-(4-Ethoxycarbonylanilino)-2-quinazolinecarboxylic acid ethyl ester

4-(4-Ethoxycarbonylanilino)-2-quinazolinecarboxylic acid ethyl ester

C20H19N3O4 (365.1375)


   

N-(4-acetamidophenyl)-4-(1,3-dioxo-2-isoindolyl)butanamide

N-(4-acetamidophenyl)-4-(1,3-dioxo-2-isoindolyl)butanamide

C20H19N3O4 (365.1375)


   

1,5-dimethyl-4-oxo-N-[2-(3-thiophenyl)ethyl]-2-pyrrolo[3,2-c]quinolinecarboxamide

1,5-dimethyl-4-oxo-N-[2-(3-thiophenyl)ethyl]-2-pyrrolo[3,2-c]quinolinecarboxamide

C20H19N3O2S (365.1198)


   
   
   
   
   
   
   
   
   
   
   
   
   

N-[4-[2-[(2E)-2-(pyridin-4-ylmethylidene)hydrazinyl]-1,3-thiazol-4-yl]phenyl]butanamide

N-[4-[2-[(2E)-2-(pyridin-4-ylmethylidene)hydrazinyl]-1,3-thiazol-4-yl]phenyl]butanamide

C19H19N5OS (365.131)


   

Ethyl 2-methyl-4,5-dioxo-1-phenyl-3-phenyldiazenylpyrrolidine-2-carboxylate

Ethyl 2-methyl-4,5-dioxo-1-phenyl-3-phenyldiazenylpyrrolidine-2-carboxylate

C20H19N3O4 (365.1375)


   

Arecaidine but-2-ynyl ester (tosylate)

Arecaidine but-2-ynyl ester (tosylate)

C18H23NO5S (365.1297)


Arecaidine but-2-ynyl ester tosylate (ABET) is a selective mAChR M2 agonist that dose-dependently decreases mean arterial pressure and heart rate in rats. Arecaidine but-2-ynyl ester tosylate can be used for cardiovascular disease research[1][2]. Arecaidine but-2-ynyl ester (tosylate) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one

5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one

C20H19N3O4 (365.1375)


   

methyl 5-{3-hydroxy-9-oxo-1h,2h-pyrrolo[2,1-b]quinazolin-3-yl}-2-(methylamino)benzoate

methyl 5-{3-hydroxy-9-oxo-1h,2h-pyrrolo[2,1-b]quinazolin-3-yl}-2-(methylamino)benzoate

C20H19N3O4 (365.1375)


   

12-[2-(dimethylamino)ethyl]-14-methoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11,13,15(19)-heptaen-17-one

12-[2-(dimethylamino)ethyl]-14-methoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11,13,15(19)-heptaen-17-one

C21H19NO5 (365.1263)


   

(1r,14s,24r)-24,25-dimethyl-5,7,13,17,19-pentaoxa-25-azaheptacyclo[12.10.1.0²,¹⁰.0⁴,⁸.0¹²,²⁴.0¹⁵,²³.0¹⁶,²⁰]pentacosa-2,4(8),9,15,20,22-hexaene

(1r,14s,24r)-24,25-dimethyl-5,7,13,17,19-pentaoxa-25-azaheptacyclo[12.10.1.0²,¹⁰.0⁴,⁸.0¹²,²⁴.0¹⁵,²³.0¹⁶,²⁰]pentacosa-2,4(8),9,15,20,22-hexaene

C21H19NO5 (365.1263)


   

11-acetyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-yl acetate

11-acetyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-yl acetate

C21H19NO5 (365.1263)


   

(12r,13s)-11-acetyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-yl acetate

(12r,13s)-11-acetyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-yl acetate

C21H19NO5 (365.1263)


   

7-demethyl-6-methoxy-5,6-dihydrochelerythrine

NA

C21H19NO5 (365.1263)


{"Ingredient_id": "HBIN013156","Ingredient_name": "7-demethyl-6-methoxy-5,6-dihydrochelerythrine","Alias": "NA","Ingredient_formula": "C21H19NO5","Ingredient_Smile": "NA","Ingredient_weight": "365.38","OB_score": "30.74255792","CAS_id": "126234-22-8","SymMap_id": "SMIT06894","TCMID_id": "NA","TCMSP_id": "MOL005084","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C20H19N3O4 (365.1375)


   

(4r,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4r,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C20H19N3O4 (365.1375)


   

2-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-3-en-1-yl pyridine-3-carboxylate

2-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-3-en-1-yl pyridine-3-carboxylate

C21H19NO5 (365.1263)


   

(1s,12r,14r,24s)-24,25-dimethyl-5,7,13,17,19-pentaoxa-25-azaheptacyclo[12.10.1.0²,¹⁰.0⁴,⁸.0¹²,²⁴.0¹⁵,²³.0¹⁶,²⁰]pentacosa-2,4(8),9,15(23),16(20),21-hexaene

(1s,12r,14r,24s)-24,25-dimethyl-5,7,13,17,19-pentaoxa-25-azaheptacyclo[12.10.1.0²,¹⁰.0⁴,⁸.0¹²,²⁴.0¹⁵,²³.0¹⁶,²⁰]pentacosa-2,4(8),9,15(23),16(20),21-hexaene

C21H19NO5 (365.1263)


   

(3s,6s)-3-[(2ar)-2ah,3h-[1,2]dioxeto[3,4-b]indol-7b-ylmethyl]-6-benzyl-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-[(2ar)-2ah,3h-[1,2]dioxeto[3,4-b]indol-7b-ylmethyl]-6-benzyl-3,6-dihydropyrazine-2,5-diol

C20H19N3O4 (365.1375)


   

(1r,5s,8s,10s)-5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one

(1r,5s,8s,10s)-5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one

C20H19N3O4 (365.1375)


   

(1r,12s,14s,24r)-24,25-dimethyl-5,7,13,17,19-pentaoxa-25-azaheptacyclo[12.10.1.0²,¹⁰.0⁴,⁸.0¹²,²⁴.0¹⁵,²³.0¹⁶,²⁰]pentacosa-2,4(8),9,15,20,22-hexaene

(1r,12s,14s,24r)-24,25-dimethyl-5,7,13,17,19-pentaoxa-25-azaheptacyclo[12.10.1.0²,¹⁰.0⁴,⁸.0¹²,²⁴.0¹⁵,²³.0¹⁶,²⁰]pentacosa-2,4(8),9,15,20,22-hexaene

C21H19NO5 (365.1263)


   

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-ol

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-ol

C21H19NO5 (365.1263)


   

(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-ol

(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-ol

C21H19NO5 (365.1263)


   

1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one

1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one

C20H19N3O4 (365.1375)


   

(2s)-2-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-3-en-1-yl pyridine-3-carboxylate

(2s)-2-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-3-en-1-yl pyridine-3-carboxylate

C21H19NO5 (365.1263)


   

4,5-bis(2h-1,3-benzodioxol-5-ylmethyl)-1-methyl-3h-imidazol-2-imine

4,5-bis(2h-1,3-benzodioxol-5-ylmethyl)-1-methyl-3h-imidazol-2-imine

C20H19N3O4 (365.1375)


   

24,25-dimethyl-5,7,13,17,19-pentaoxa-25-azaheptacyclo[12.10.1.0²,¹⁰.0⁴,⁸.0¹²,²⁴.0¹⁵,²³.0¹⁶,²⁰]pentacosa-2,4(8),9,15,20,22-hexaene

24,25-dimethyl-5,7,13,17,19-pentaoxa-25-azaheptacyclo[12.10.1.0²,¹⁰.0⁴,⁸.0¹²,²⁴.0¹⁵,²³.0¹⁶,²⁰]pentacosa-2,4(8),9,15,20,22-hexaene

C21H19NO5 (365.1263)


   

(4s,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4s,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C20H19N3O4 (365.1375)


   

10,11-dimethoxy-2,3,6,7-tetrahydro-1,4-dioxa-8-azapentaphen-9-one

10,11-dimethoxy-2,3,6,7-tetrahydro-1,4-dioxa-8-azapentaphen-9-one

C21H19NO5 (365.1263)


   

(1s,4r)-1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one

(1s,4r)-1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one

C20H19N3O4 (365.1375)


   

(12s,13r)-11-acetyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-yl acetate

(12s,13r)-11-acetyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-yl acetate

C21H19NO5 (365.1263)